Rapamycin for Cats with Hypertrophic Cardiomyopathy (HCM)

In this concise monologue, Dr. Kevin Toman, the "Longevity Vet" with 38 years of veterinary experience, presents rapamycin as a major advancement in feline medicine. He explains that recent research shows rapamycin can halt or significantly slow the progression of hypertrophic cardiomyopathy (HCM), a previously fatal heart disease in cats. He contextualizes rapamycin as the most extensively studied longevity drug, noting its ability to extend lifespan by up to 15% across mammalian species, reduce the severity of feline stomatitis, and its ongoing investigation for chronic kidney disease benefits. Dr. Toman urges owners of older cats, especially those with cardiac issues, to consider rapamycin as part of their therapeutic regimen and offers his contact information for further guidance.










